• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

MATSUSHITA Marimo  松下 まりも

ORCIDConnect your ORCID iD *help
… Alternative Names

佐藤まりも

松下 まりも(佐藤まりも)  マツシタ マリモ

SATO Marimo  佐藤 まりも

佐藤 まりも  サトウ マリモ

Less
Researcher Number 50401253
Other IDs
Affiliation (based on the past Project Information) *help 2007 – 2015: The University of Tokyo, 医科学研究所, 助教
Review Section/Research Field
Principal Investigator
General surgery / Immunology
Except Principal Investigator
General surgery
Keywords
Principal Investigator
樹状細胞 / IL-23 / 抗腫瘍効果 / 癌免疫療法 / 遺伝子治療 / Th17 / 免疫監視機構 / TIM-3 / PD-1 / CTLA-4 … More / interleukin-23 / 慢性炎症 / IL-17 / 実験外科学 / がん免疫療法 / インターロイキン23 / アデノウィルスベクター / インターロイキン-23 / 癌治療 / サイトカイン / 免疫学 / Th1 / 癌ワクチン … More
Except Principal Investigator
ウイルスベクター / 遺伝子治療 / 細胞療法 / 樹状細胞 / トランスレーショナルリサーチ / 科学教育 / 細胞医療 / 再生医療 / トランスレーショナル・リサーチ / ウィルスベクター / 臨床研究 / 腫瘍免疫 / 実験外科学 Less
  • Research Projects

    (7 results)
  • Research Products

    (68 results)
  • Co-Researchers

    (7 People)
  •  T細胞不活化制御による癌に対する遺伝子細胞療法の開発Principal Investigator

    • Principal Investigator
      松下 まりも (佐藤まりも / 佐藤 まりも / 松下 まりも(佐藤まりも))
    • Project Period (FY)
      2013 – 2015
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      General surgery
    • Research Institution
      The University of Tokyo
  •  The elucidation of chronic inflammation by IL-23/Th17 and the application to cancer immunotherapyPrincipal Investigator

    • Principal Investigator
      MATSUSHITA Marimo (SATO Marimo)
    • Project Period (FY)
      2011 – 2012
    • Research Category
      Grant-in-Aid for Young Scientists (B)
    • Research Field
      General surgery
    • Research Institution
      The University of Tokyo
  •  Development of quality prediction / rationalization system in autologous cell therapy which can conquer individual difference

    • Principal Investigator
      KATANO HISAKO
    • Project Period (FY)
      2010 – 2013
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Research Field
      General surgery
    • Research Institution
      The University of Tokyo
  •  Preclinical Development of Cellular Gene therapy using Viral Vector

    • Principal Investigator
      TAHARA Hideaki
    • Project Period (FY)
      2009 – 2011
    • Research Category
      Grant-in-Aid for Scientific Research (A)
    • Research Field
      General surgery
    • Research Institution
      The University of Tokyo
  •  Development of cancer immunotherapy using dendritic cells genetically modified to express Interleukin-23Principal Investigator

    • Principal Investigator
      SATO Marimo
    • Project Period (FY)
      2009 – 2010
    • Research Category
      Grant-in-Aid for Young Scientists (B)
    • Research Field
      General surgery
    • Research Institution
      The University of Tokyo
  •  Development for DC Vaccine using Th1/Th17 axis by IL-23Principal Investigator

    • Principal Investigator
      SATO Marimo
    • Project Period (FY)
      2007 – 2008
    • Research Category
      Grant-in-Aid for Young Scientists (B)
    • Research Field
      General surgery
    • Research Institution
      The University of Tokyo
  •  癌ペプチドワクチン療法に有用な樹状細胞サブセットの解析Principal Investigator

    • Principal Investigator
      佐藤 まりも
    • Project Period (FY)
      2001
    • Research Category
      Grant-in-Aid for JSPS Fellows
    • Research Field
      Immunology
    • Research Institution
      Hokkaido University

All 2015 2014 2013 2012 2011 2010 2009 2008 2007 Other

All Journal Article Presentation Book

  • [Book] Molecular Profiling of Immunotherapeutic Resistance, Cancer Immunotherapy (Second Edition)2013

    • Author(s)
      Davide Bedognetti, Ena Wang, Marimo Sato-Matsushita, Francesco M. Marincola, Maria Libera Ascierto
    • Publisher
      Elsevier
    • Data Source
      KAKENHI-PROJECT-25461974
  • [Book] 細胞療法におけるGMP化-樹状細胞を例として-,『がん免疫法-実用化へのチャレンジ-』2010

    • Author(s)
      佐藤まりも, 田原秀晃
    • Publisher
      シーエムシー出版
    • Data Source
      KAKENHI-PROJECT-21791244
  • [Book] がん免疫療法-実用化へのチャレンジ-(細胞療法におけるGMP化-樹状細胞を例として-)第20章2010

    • Author(s)
      佐藤まりも, 田原秀晃
    • Data Source
      KAKENHI-PROJECT-21791244
  • [Book] 最新医学(サイトカインの腫瘍免疫における役割とその利用, 11月号64巻)2009

    • Author(s)
      佐藤まりも、田原秀晃
    • Total Pages
      7
    • Data Source
      KAKENHI-PROJECT-21791244
  • [Book] IL-23の全身投与による抗腫瘍効果2008

    • Author(s)
      佐藤まりも、田原秀晃
    • Total Pages
      4
    • Publisher
      先端医学社
    • Data Source
      KAKENHI-PROJECT-19790913
  • [Book] がんワクチンの開発2007

    • Author(s)
      佐藤まりも、田原秀晃
    • Total Pages
      4
    • Publisher
      月刊・治療学
    • Data Source
      KAKENHI-PROJECT-19790913
  • [Journal Article] Early activation and interferon-Y production of tumor-infiltrating mature CD27 high natural killer cells2011

    • Author(s)
      Y.Hayakawa
    • Journal Title

      Cancer Sci

      Volume: 102 Issue: 11 Pages: 1967-1971

    • DOI

      10.1111/j.1349-7006.2011.02042.x

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20220009, KAKENHI-PROJECT-21249069, KAKENHI-PROJECT-22659016, KAKENHI-PUBLICLY-23112519, KAKENHI-PROJECT-23300355, KAKENHI-PROJECT-23701073
  • [Journal Article] Early activation and interferon-γ production of tumor-infiltrating mature CD27(high) natural killer cells2011

    • Author(s)
      Yoshihiro Hayakawa, Marimo Sato-Matsushita, Kazuyoshi Takeda, Yoichiro Iwakura, Hideaki Tahara, Tatsuro Irimura
    • Journal Title

      Cancer Science

      Volume: 102 Pages: 1967-1971

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23791482
  • [Journal Article] Phase I clinical trial of the vaccination for the patients with metastatic melanoma using gp100-derived epitope peptide restricted to HLA-A* 24022010

    • Author(s)
      Baba T, Sato-Matsushita M, Kanamoto A, Itoh A, Oyaizu N, Inoue Y, Kawakami Y, Tahara H.
    • Journal Title

      J Translational Medicine

      Volume: 8巻 Issue: 1 Pages: 84-95

    • DOI

      10.1186/1479-5876-8-84

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21249069
  • [Journal Article] Phase I clinical trial of the vaccination for the patients with metastatic melanoma using gp100-derived epitope peptide restricted to HLA-A*24022010

    • Author(s)
      Toshiyuki Baba, Marimo Sato-Matsushita (Contributed equally), Akira Kanamoto, Akihiko Itoh, Naoki Oyaizu, Yusuke Inoue, Yutaka Kawakami, Hideaki Tahara
    • Journal Title

      Journal of Translational Medicine

      Volume: 84 Pages: 8-20

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21791244
  • [Journal Article] Phase I clinical trial of the vaccination for the patients with metastatic melanoma using gp100-derived epitope peptide restricted to HLA-A*2402.2010

    • Author(s)
      Toshiyuki Baba, Marimo Sato-Matsushita, Akira Kanamoto, Akihiko Itoh, Naoki Oyaizu, Yusuke Inoue, Yutaka Kawakami, Hideaki Tahara
    • Journal Title

      Journal of Translational Medicine 8

      Pages: 84-84

    • Data Source
      KAKENHI-PROJECT-21791244
  • [Journal Article] Phase I clinical trial of the vaccination for the patients with metastatic melanoma using gp100-derived epitope peptide restricted to HLA-A*24022010

    • Author(s)
      Baba T, Sato-Matsushita M, Kanamoto A, Itoh A, Oyaizu N, Inoue Y, Kawakami Y, Tahara H
    • Journal Title

      J Translational Medicine

      Volume: 8 Pages: 84-95

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21249069
  • [Journal Article] Emerging concepts in biomarker discovery ; The US-Japan Workshop on Immunological Molecular Markers in Oncology.2009

    • Author(s)
      Hideaki Tahara, Marimo Sato, Magdalena Thurin, Ena Wang, Lisa H Butterfield, Mary L Disis, Bernard A Fox, Peter P Lee, Jon M Wigginton, Stefan Ambs, Yasunori Akutsu, Damien Chaussabel, Yuichiro Doki, Yoshihiko Hirohashi, Kohzoh Imai, James Jacobson, Masahisa Jinushi, Akira Kanamoto, Mohammed Kashani-Sabet, Kazunori Kato, Yutaka Kawakami, John M Kirkwood, Michael T Lotze, Hisahiro Matsubara, Kiminori Nakamura, Hiroyoshi Nishikawa, Zoltan Pos, Raj Puri, Antoni Ribas, Noriyuki Sato, Hiroshi Shiku, Howard Streicher, David F Stroncek, Hiroya Takeuchi, Minoru Toyota, Hisashi Wada, Tomonori Yaguchi, Yingdong Zhao, Francesco M Marincola
    • Journal Title

      J Translational Med. 7

      Pages: 45-45

    • Data Source
      KAKENHI-PROJECT-21791244
  • [Journal Article] Emerging concepts in biomarker discovery ; The US-Japan Workshop on Immunological Molecular Markers in Oncology2009

    • Author(s)
      Hideaki Tahara, Marimo Sato, Magdalena, et al.
    • Journal Title

      Journal of Translational Medicine 7

      Pages: 45-70

    • Data Source
      KAKENHI-PROJECT-21791244
  • [Journal Article] Milk Fat Globule EGF-8 blockade triggers tumor destruction through coordinated cell-autonomous and immune-mediated mechanisms2009

    • Author(s)
      Jinushi M, Sato M, Kanamoto A, Itoh A, Nagai S, Koyasu S, Dranoff G, and Tahara H.
    • Journal Title

      Journal of Experimental Medicine

      Volume: 100巻 Issue: 6 Pages: 1389-1396

    • DOI

      10.1084/jem.20082614

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21249069, KAKENHI-PROJECT-21689031
  • [Journal Article] Milk Fat Globule EGF-8 Blockade Triggers Tumor Destruction through Coordinated Cell-Autonomous and Immune-Mediated Mechanisms2009

    • Author(s)
      Masahisa Jinushi, Marimo Sato, Akira Kanamoto, Akihiko Itoh, Shigenori Nagai, Shigeo Koyasu, Glenn Dranoff, Hideaki Tahara
    • Journal Title

      Journal of Experimental Medicine 206

      Pages: 1317-1326

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21791244
  • [Journal Article] Milk Fat Globule EGF-8 Blockade Triggers Tumor Destruction through Coordinated Cell-Autonomous and Immune-Mediated Mechanisms.2009

    • Author(s)
      Masahisa Jinushi, Marimo Sato, Akira Kanamoto, Akihiko Itoh1, Shigenori Nagai, Shigeo Koyasu, Glenn Dranoff, Hideaki Tahara
    • Journal Title

      J Exp Med 206

      Pages: 1317-1326

    • Data Source
      KAKENHI-PROJECT-21791244
  • [Journal Article] Milk Fat Globule EGF-8 blockade triggers tumor destruction through coordinated cell-autonomous and immune-mediated mechanisms.2009

    • Author(s)
      Jinushi M, Sato M, Kanamoto A, Itoh A, Nagai S, Koyasu S, Dranoff G, Tahara H.
    • Journal Title

      Journal of Experimental Medicine 100

      Pages: 1389-1396

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21249069
  • [Journal Article] Combined mobilization and stimulation of tumor-infiltrating dendritic cells and natural killer cells with Flt3 ligand and IL-18 in vivo induces systemic anti-tumor immunity2008

    • Author(s)
      Testuya Saito, Takuya Takayama, Tadashi Osaki, Shigenori Nagai, Toshihiro Suzuki, Marimo Sato, Hiroyuki Kuwano and Hideaki Tahara
    • Journal Title

      Cancer Sci 99

      Pages: 36-2028

    • NAID

      10024012190

    • Data Source
      KAKENHI-PROJECT-19790913
  • [Journal Article] Combined mobilization and stimulation of tumor-infiltrating dendritic cells and natural killer cells with Flt3 ligand and IL-18 in vivo induces systemic anti-tumor immunity2008

    • Author(s)
      Testuya Saito, Takuya Takayama, Tadashi Osaki, Shigenori Nagai, Toshihiro Suzuki, Marimo Sato, Hiroyuki Kuwano and Hideaki Tahara
    • Journal Title

      Cancer Science 99

      Pages: 2028-2036

    • NAID

      10024012190

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19790913
  • [Journal Article] Systemic Administration of IL-23 Induces Potent Anti-tumor Immunity Primarily Mediated through Th1-type Response in Association with the Endogenously Expressed IL-122007

    • Author(s)
      Teruo Kaiga, Marimo Sato,Hide Kaneda, Yoichiro Iwakura, Tadatoshi Takayamam, and Hideaki Tahara
    • Journal Title

      J Immunol 178

      Pages: 7571-7580

    • Data Source
      KAKENHI-PROJECT-19790913
  • [Journal Article] Potent anti-tumor effects of combination therapy using Interleukin-23 and a-galactosylceramide2007

    • Author(s)
      Hide Kaneda, Marimo Sato, Teruo Kaiga, Yoko Nango, Takeshi Kusafuka, and Hideaki Tahara
    • Journal Title

      J. Nihon Univ. Med. Ass 66

      Pages: 60-69

    • Data Source
      KAKENHI-PROJECT-19790913
  • [Journal Article] Systemic Administration of IL-23 Induces Potent Anti-tumor Immunity Primarily Mediated through Th1-type Response in Association with the Endogenously Expressed IL-122007

    • Author(s)
      Teruo Kaiga, Marimo Sato, Hide Kaneda, Yoichiro Iwakura, Tadatoshi Takayamam, and Hideaki Tahara
    • Journal Title

      J Immunol 178

      Pages: 7571-7580

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19790913
  • [Presentation] Novel function of NK cell to regulate cancer-associated inflammation2015

    • Author(s)
      小倉圭介、松下(佐藤) まりも、田原秀晃、済木育夫、早川芳弘
    • Organizer
      第74回日本癌学会学術総会
    • Place of Presentation
      名古屋国際会議場(愛知県名古屋市)
    • Year and Date
      2015-10-08
    • Data Source
      KAKENHI-PROJECT-25461974
  • [Presentation] Time-scale analysis of interplay between occult immunogenic tumor and immune response2015

    • Author(s)
      Marija Mojic, Marimo Sato-Matsushita, Hideaki Tahara, Ikuo Saiki, Yoshihiro Hayakawa
    • Organizer
      第44回日本免疫学会学術集会
    • Place of Presentation
      札幌コンベンションセンター(北海道札幌市)
    • Year and Date
      2015-11-18
    • Data Source
      KAKENHI-PROJECT-25461974
  • [Presentation] Therapeutic efficacy of modified DC2014

    • Author(s)
      Marimo Sato-Matsushita and Hideaki Tahara
    • Organizer
      第24回日本樹状細胞研究会総会
    • Place of Presentation
      山形
    • Year and Date
      2014-06-20
    • Invited
    • Data Source
      KAKENHI-PROJECT-25461974
  • [Presentation] IL-17-producing NK1.1- CD27- T cells promote tumor malignant progression by inducing inflammatorymicroenvironment2012

    • Author(s)
      Yoshitaka Kimura, Marimo Sato-Matsushita, Hideaki Tahara, Tatsuro Irimura, Yoshihiro Hayakawa
    • Organizer
      第41回日本免疫学会総会・学術集会
    • Place of Presentation
      神戸国際会議場,神戸
    • Data Source
      KAKENHI-PROJECT-23791482
  • [Presentation] IL-17-producing NK1.1+ CD27+ T cells promote tumor malignant progression by inducing inflammatory microenvironment2012

    • Author(s)
      Yoshitaka Kimura, Marimo Sato-Matsushita, Hideaki Tahara, Tatsuro Irimura
    • Organizer
      20th International Symposium on Molecular Cell Biology of Macrophages 2012
    • Place of Presentation
      Sanjo Conference Hall, Tokyo
    • Data Source
      KAKENHI-PROJECT-23791482
  • [Presentation] IL-17-producing NK1.1+ CD27+ T cells promote tumor malignant progression by inducing inflammatory microenvironment2012

    • Author(s)
      Yoshitaka Kimura, Marimo Sato-Matsushita, Hideaki Tahara, Tatsuro Irimura, Yoshihiro Hayakawa
    • Organizer
      第41回日本免疫学会総会・学術集会
    • Place of Presentation
      神戸国際会議場、神戸
    • Data Source
      KAKENHI-PROJECT-23791482
  • [Presentation] IL-17-producing NK1.1- CD27- T cells promote tumor malignant progression by inducing inflammatory microenvironment2012

    • Author(s)
      早川芳弘,佐藤(松下)まりも,田原秀晃,済木育夫,入村達郎
    • Organizer
      第71回日本癌学会学術総会
    • Place of Presentation
      ロイトン札幌, 札幌
    • Data Source
      KAKENHI-PROJECT-23791482
  • [Presentation] IL-17-producing NK1.1- CD27- T cells promote tumor malignant progression by inducing inflammatory microenvironment2012

    • Author(s)
      Yoshitaka Kimura, Marimo Sato-Matsushita, Hideaki Tahara, Tatsuro Irimura, Yoshihiro Hayakawa
    • Organizer
      20th International Symposium on Molecular Cell Biology of Macrophages 2012
    • Place of Presentation
      Sanjo Conference Hall, The University of Tokyo, Tokyo
    • Data Source
      KAKENHI-PROJECT-23791482
  • [Presentation] IL-17-producing NK1.1+ CD27+ T cells promote tumor malignant progression by inducing inflammatory microenvironment2012

    • Author(s)
      Yoshihiro Hayakawa, Yoshitaka Kimura, Naoki Tsunekawa, Marimo Sato-Matsushita, Hideaki Tahara, Ikuo Saiki, Tatsuro Irimura
    • Organizer
      第16回日本がん免疫学会総会
    • Place of Presentation
      北海道大学学術交流センター、札幌
    • Data Source
      KAKENHI-PROJECT-23791482
  • [Presentation] IL-17-producing NK1.1-CD27- T cells promote tumor malignant progression by inducing inflammatorymicroenvironment2012

    • Author(s)
      Yoshihiro Hayakawa, Yoshitaka Kimura, Naoki Tsunekawa, Marimo Sato-Matsushita, Hideaki Tahara, Ikuo Saiki, Tatsuro Irimura
    • Organizer
      第16回日本がん免疫学会総会
    • Place of Presentation
      北海道大学学術交流会館、札幌
    • Data Source
      KAKENHI-PROJECT-23791482
  • [Presentation] IL-17-producing NK1.1+ CD27+ T cells promote tumor malignant progression by inducing inflammatory microenvironment2012

    • Author(s)
      早川 芳弘、佐藤(松下) まりも、田原 秀晃、済木 育夫、入村 達郎
    • Organizer
      第71回日本癌学会学術総会
    • Place of Presentation
      ロイトン札幌、札幌
    • Data Source
      KAKENHI-PROJECT-23791482
  • [Presentation] Induction of memory Th1 cell responses with IL-23 produced by human mature dendritic cells stimulated with OK-432 combined with PGE22011

    • Author(s)
      Marimo Sato-Matsushita, Hisako Katano and Hideaki Tahara
    • Organizer
      第21回日本樹状細胞研究会
    • Place of Presentation
      福岡
    • Data Source
      KAKENHI-PROJECT-23791482
  • [Presentation] Evidences for cancer immune-escalation process and the role of inflammatory cytokines2011

    • Author(s)
      Yoshihiro Hayakawa, Marimo Sato-Matsushita, Yoichiro Iwakura, Hideaki Tahara, Tatsuro Irimura
    • Organizer
      第40回日本免疫学会学術集会
    • Place of Presentation
      幕張メッセ
    • Data Source
      KAKENHI-PROJECT-23791482
  • [Presentation] Induction of systemic and therapeutic antitumor immunity using intratumoral injection of bone-marrow derived dendritic cells genetically modified to express IL-232010

    • Author(s)
      Marimo Sato, Kimiyasu Yoneyama, Yuko Kitagawa, Hideaki Tahara
    • Organizer
      第14回基盤的癌免疫研究会総会
    • Place of Presentation
      熊本 KKRホテル熊本
    • Year and Date
      2010-07-23
    • Data Source
      KAKENHI-PROJECT-21791244
  • [Presentation] Induction of systemic and therapeutic antitumor immunity using intratumoral injection of bone-marrow derived dendritic cells genetically modified to express IL-232010

    • Author(s)
      Marimo Sato, Kimiyasu Yoneyama, Takafumi Nakamura, Yuko Kitagawa, Hideaki Tahara
    • Organizer
      第14回基盤的癌免疫研究会総会
    • Place of Presentation
      熊本
    • Data Source
      KAKENHI-PROJECT-21791244
  • [Presentation] Translational research of clinical dendritic cell therapy using OK-432 and prostaglandin E2(Phase I study)2010

    • Author(s)
      Sato-Matsushita M, Kanamoto A, Katano H, Itoh A, Tahara H
    • Organizer
      14^<th> International Congress of Immunology
    • Place of Presentation
      神戸市、神戸ポートピアホテル神戸コンベンションセンター
    • Year and Date
      2010-08-27
    • Data Source
      KAKENHI-PROJECT-21249069
  • [Presentation] Induction of antitumor effects using intratumoral injection of bone-marrow derived dendritic cells genetically modified to express IL-232010

    • Author(s)
      Marimo Sato, Kimiyasu Yoneyama, Yuko Kitagawa, Hideaki Tahara
    • Organizer
      第20回日本樹状細胞研究会総会
    • Place of Presentation
      新潟 朱鷺メッセ
    • Year and Date
      2010-06-19
    • Data Source
      KAKENHI-PROJECT-21791244
  • [Presentation] IL-23併用投与によるDNAワクチンの臨床応用への検討2010

    • Author(s)
      米山公康、佐藤まりも、金本彰、伊藤精彦、田原秀晃
    • Organizer
      第110回日本外科学会定期学術集会
    • Place of Presentation
      名古屋
    • Data Source
      KAKENHI-PROJECT-21791244
  • [Presentation] Induction of systemic and therapeutic antitumor immunity using dendritic cells genetically modified to express IL-232010

    • Author(s)
      Marimo Sato, Kimiyasu Yoneyama, Takafumi Nakamura, Hisako Katano, Yuko Kitagawa, Hideaki Tahara
    • Organizer
      第69回日本癌学会学術総会
    • Place of Presentation
      大阪
    • Data Source
      KAKENHI-PROJECT-21791244
  • [Presentation] Induction of antitumor effects using intratumoral injection of bone-marrow derived dendritic cells genetically modified to express IL-232010

    • Author(s)
      Marimo Sato, Kimiyasu Yoneyama, Yuko Kitagawa, Hideaki Tahara
    • Organizer
      第20回日本樹状細胞研究会総会
    • Place of Presentation
      新潟
    • Data Source
      KAKENHI-PROJECT-21791244
  • [Presentation] Significant enhancement of antigen-specific antitumor effects of DNA vaccine with systemic administration of interleukin-232010

    • Author(s)
      米山公康、佐藤まりも、田原秀晃
    • Organizer
      日本外科学会学術総会
    • Place of Presentation
      名古屋市
    • Year and Date
      2010-04-09
    • Data Source
      KAKENHI-PROJECT-21249069
  • [Presentation] Significant enhancement of antigen-specific antitumor effects of DNA vaccine with systemic administration of interleukin-232010

    • Author(s)
      米山公康、佐藤まりも、田原秀晃
    • Organizer
      日本外科学会学術総会
    • Place of Presentation
      名古屋市、名古屋国際会議場
    • Year and Date
      2010-04-09
    • Data Source
      KAKENHI-PROJECT-21249069
  • [Presentation] Induction of systemic and therapeutic antitumor immunity using dendritic cells genetically modified to express IL-232010

    • Author(s)
      Marimo Sato, Kimiyasu Yoneyama, Takafumi Nakamura, Hisako Katano, Yuko Kitagawa, Hideaki Tahara
    • Organizer
      第69回日本癌学会学術総会
    • Place of Presentation
      大阪 リーガロイヤルホテル大阪
    • Year and Date
      2010-09-22
    • Data Source
      KAKENHI-PROJECT-21791244
  • [Presentation] Translational research of clinical dendritic cell therapy using OK-432 and prostaglandin E2(Phase I study)2010

    • Author(s)
      Sato-Matsushita M, Kanamoto A, Katano H, Itoh A, Tahara H
    • Organizer
      14^th International Congress of Immunology
    • Place of Presentation
      神戸市
    • Year and Date
      2010-08-27
    • Data Source
      KAKENHI-PROJECT-21249069
  • [Presentation] Cancer immunotherapy using monocyte-derived DCs stimulated with OK-432 and prostaglandin E_2 pulsed with gp100 epitope peptide in malignant melanoma2009

    • Author(s)
      Marimo Sato, Akira Kanamoto, Masahisa Jinushi, Hisako Katano, Kimiyasu Yoneyama, Akihiko Itoh, Hideaki Tahara
    • Organizer
      第13回基盤的癌免疫研究会総会
    • Place of Presentation
      小倉
    • Data Source
      KAKENHI-PROJECT-21791244
  • [Presentation] In situ antitumor immunotherapy with blockade of MFG-E8 and chemotherapy against solid and hematological tumors2009

    • Author(s)
      Masahisa Jinushi, Marimo Sato, Akira Kanamoto, Akihiko Itoh, Hideaki Tahara
    • Organizer
      第68回日本癌学会学術総会
    • Place of Presentation
      横浜
    • Data Source
      KAKENHI-PROJECT-21791244
  • [Presentation] Antigen-specific antitumor effects of DNA vaccine are significantly enhanced with systemic administration of IL-232009

    • Author(s)
      Kimiyasu Yoneyama, Marimo Sato, Masahisa Jinushi, Yuko Kitagawa, Hideaki Tahara
    • Organizer
      第39回日本免疫学会学術集会
    • Place of Presentation
      大阪国際会議場(大阪)
    • Year and Date
      2009-12-04
    • Data Source
      KAKENHI-PROJECT-21791244
  • [Presentation] Clinical dendritic cell therapy using OK-432 and prostaglandin E_2 (Phase I study)2009

    • Author(s)
      Marimo Sato, Akira Kanamoto, Masahisa Jinushi, Hisako Katano, Kimiyasu Yoneyama, Akihiko Itoh, Hideaki Tahara
    • Organizer
      第19回日本樹状細胞研究会総会
    • Place of Presentation
      淡路
    • Data Source
      KAKENHI-PROJECT-21791244
  • [Presentation] Cancer vaccine against malignant melanoma using monocyte-derived dendritic cells stimulated with OK-432 and PGE22009

    • Author(s)
      佐藤まりも、田原秀晃, 他5名
    • Organizer
      日本癌学会総会
    • Place of Presentation
      横浜市
    • Year and Date
      2009-10-02
    • Data Source
      KAKENHI-PROJECT-21249069
  • [Presentation] Cancer vaccine against malignant melanoma using monocyte derived dendritic cells stimulated with OK-432 and PGE_22009

    • Author(s)
      Marimo Sato, Akira Kanamoto, Masahisa Jinushi, Hisako Katano, Kimiyasu Yoneyama, Akihiko Itoh, Hideaki Tahara
    • Organizer
      第68回日本癌学会学術総会
    • Place of Presentation
      横浜
    • Data Source
      KAKENHI-PROJECT-21791244
  • [Presentation] Antigen-specific antitumor effects of DNA vaccine are significantly enhanced with systemic administration of IL-232009

    • Author(s)
      Kimiyasu Yoneyama, Marimo Sato, Masahisa Jinushi, Yuko Kitagawa, Hideaki Tahara
    • Organizer
      第39回日本免疫学会学術集会
    • Place of Presentation
      大阪
    • Data Source
      KAKENHI-PROJECT-21791244
  • [Presentation] Systemic administration of IL-23 induces potent anti-tumor immunity primarily mediated through Th1-type response2008

    • Author(s)
      Marimo Sato, Hide Kaneda, Kimiyasu Yoneyama, Hideaki Tahara
    • Organizer
      An AACR International Conference
    • Place of Presentation
      Jordan.
    • Data Source
      KAKENHI-PROJECT-19790913
  • [Presentation] Systemic administration of IL-23 induces potent anti-tumor immunity primarily mediated through Th1-type response in association with the endogenously expressed IL-122008

    • Author(s)
      Marimo Sato, Hide Kaneda, Teruo Kaiga and Hideaki Tahara
    • Organizer
      99^<th> Annual Meeting of AACR
    • Place of Presentation
      San Diego
    • Data Source
      KAKENHI-PROJECT-19790913
  • [Presentation] Systemic Administration of IL-23 Induces Potent Anti-tumor Immunity Primarily Mediated through Th1-type Response in association with the endogenous expressed IIL-122008

    • Author(s)
      Marimo SATO, Hide KANEDA, Teruo KAIGA and Hideaki TAHARA
    • Organizer
      AACR International Conference: Advanced in Cancer research
    • Place of Presentation
      Dead Sea, Jordan
    • Data Source
      KAKENHI-PROJECT-19790913
  • [Presentation] Systemic administration of IL-23 induces potent anti-tumor immunity primarily mediated through Thl-type response in association with the endogenously expressed IL-122008

    • Author(s)
      Marimo Sato, Hide Kaneda, Teruo Kaiga and Hideaki Tahaia
    • Organizer
      99^<th> Annual Meeting of AACR
    • Place of Presentation
      San Diego, USA
    • Data Source
      KAKENHI-PROJECT-19790913
  • [Presentation] T Systemic administration of IL-23 induces potent anti-tumor immunity and both Th1-and Th17-type responses2007

    • Author(s)
      佐藤まりも、金田英秀、海賀照夫、田原秀晃
    • Organizer
      第66回 日本癌学会学術総会 シンポジウム
    • Place of Presentation
      横浜
    • Data Source
      KAKENHI-PROJECT-19790913
  • [Presentation] Th1 and Th17 in IL-23 induced anti-tumor immune responses2007

    • Author(s)
      佐藤まりも、金田英秀、小松邦光、海賀照夫、田原秀晃
    • Organizer
      第37回 日本免疫学会学術総会 ワークショップ
    • Place of Presentation
      東京
    • Data Source
      KAKENHI-PROJECT-19790913
  • [Presentation] Potent anti-tumor effects of combination therapy using Interleukin-23 and α-galactosylceramide2007

    • Author(s)
      Hide Kaneda, Marimo Sato, Hideaki Tahara
    • Organizer
      98th Annual meeting of AACR
    • Place of Presentation
      Los Angels, USA
    • Data Source
      KAKENHI-PROJECT-19790913
  • [Presentation] Potent anti-tumor effects of combination therapy using Interleukin-23 and α-galactosylceramide2007

    • Author(s)
      Hide Kaneda, Marimo Sato, Hideaki Tahara
    • Organizer
      98^<th> Annual Meeting of AACR
    • Place of Presentation
      Los Angles
    • Data Source
      KAKENHI-PROJECT-19790913
  • [Presentation] IL-23 の全身投与によるTh1 およびTh17誘導を介した抗腫瘍効果2007

    • Author(s)
      金田英秀、佐藤まりも、海賀照夫、田原秀晃
    • Organizer
      第11回基盤的癌免疫研究会総会
    • Place of Presentation
      東京
    • Data Source
      KAKENHI-PROJECT-19790913
  • [Presentation] Potent anti-tumor immunity and both Th1 and Th17 promotion associated with IL-23 administration2007

    • Author(s)
      Hideaki Tahara, Hide Kaneda, Teruo Kaiga and Marimo Sato
    • Organizer
      第37回日本免疫学会学術総会
    • Place of Presentation
      東京
    • Data Source
      KAKENHI-PROJECT-19790913
  • [Presentation] Th1 and Th17 in IL-23 induced anti-tumor immune responses2007

    • Author(s)
      Marimo Sato, Hide Kaneda, Kunimitsu Komatsu, Teruo Kaiga and Hideaki Tahara
    • Organizer
      第37回日本免疫学会学術総会
    • Place of Presentation
      東京
    • Data Source
      KAKENHI-PROJECT-19790913
  • [Presentation] Therapeutic efficacy of the treatment with monoclonal antibody and dendritic cells genetically modified to express IL-12 in vivo.

    • Author(s)
      Marimo Sato-Matsushita and Hideaki Tahara
    • Organizer
      第23回日本樹状細胞研究会
    • Place of Presentation
      京都国際会館、京都
    • Data Source
      KAKENHI-PROJECT-25461974
  • [Presentation] NK cell IFN-gamma as a primary effector pathway for controlling tumor growth

    • Author(s)
      小倉圭介, 松下(佐藤)まりも, 田原秀晃, 済木育夫, 早川芳弘
    • Organizer
      第73回日本癌学会学術総会
    • Place of Presentation
      横浜
    • Year and Date
      2014-09-25 – 2014-09-27
    • Data Source
      KAKENHI-PROJECT-25461974
  • [Presentation] Cancer immune escalation process triggered by activation of gamma-delta T17 cells through MyD88/IL-23 cascade

    • Author(s)
      Yoshitaka Kimura, Marimo Sato-Matsushita, Takayuki Yoshimoto, Hideaki Tahara, Ikuo Saiki, Tatsuro Irimura, Yoshihiro Hayakawa
    • Organizer
      第42回日本免疫学会学術集会
    • Place of Presentation
      幕張メッセ、千葉
    • Data Source
      KAKENHI-PROJECT-25461974
  • 1.  TAHARA Hideaki (70322071)
    # of Collaborated Projects: 3 results
    # of Collaborated Products: 15 results
  • 2.  KANAMOTO Akira (10386021)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 6 results
  • 3.  JIMUSHI Masahisa (40318085)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 2 results
  • 4.  ITO Akihiko (90241984)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 6 results
  • 5.  KATANO HISAKO (50376620)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 6.  NAKAMUTA Takahumi (70432911)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 7.  KATANO Harutaka (70321867)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi